BiondVax and European UNISEC Consortium to Host Universal Flu Vaccine Conference
February 08, 2018 at 10:40 AM EST
BiondVax Pharmaceuticals Ltd. developer of a Universal Flu Vaccine candidate currently in preparation for a Phase 3 clinical trial, and the European UNISEC consortium announced today they will co-host the Annual UNISEC Consortium Meeting.
